Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
Artiva Biotherapeutics Insider Sold Shares Worth $255,746, According to a Recent SEC Filing

Artiva Biotherapeutics Insider Sold Shares Worth $255,746, According to a Recent SEC Filing

MT newswireMT newswire2026/09/09 20:09
04:09 PM EDT, 09/09/2026 (MT Newswires) -- Fred Aslan, Director, Chief Executive Officer, on September 08, 2026, sold 23,429 shares in Artiva Biotherapeutics (ARTV) for $255,746. Following the Form 4 filing with the SEC, Aslan has control over a total of 1,449,765 common shares of the company, with 1,449,765 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1817241/000119312526386431/xslF345X05/ownership.xml
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!